Pharmacokinetics of oral vitamin D3 and calcifediol

Bone

Volumn 59, Issue , 2014, Pages 14-19

  Jetter, Alexander ^a   Egli, Andreas ^b,c   Dawson Hughes, Bess ^d   Staehelin, Hannes B ^e   Stoecklin, Elisabeth ^f   Goessl, Richard ^a   Henschkowski, Jana ^b,c   Bischoff Ferrari, Heike A ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c Stadtspital Waid   (Switzerland)

^d TUFTS UNIVERSITY   (United States)

^e UNIVERSITY OF BASEL   (Switzerland)

^f DSM NUTRITIONAL PRODUCTS LTD   (Switzerland)

Author keywords

Calcifediol; Pharmacokinetics; Plasma concentrations; Supplementation

Indexed keywords

CALCIFEDIOL; COLECALCIFEROL;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; MAXIMUM PLASMA CONCENTRATION; MORNING DOSAGE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, ORAL; AGED; CALCIFEDIOL; DEMOGRAPHY; DIETARY SUPPLEMENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MIDDLE AGED; TIME FACTORS;

EID: 84887520113     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2013.10.014     Document Type: Article

References (26)

1. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., Gordon C.M., Hanley D.A., Heaney R.P., et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011, 96:1911-1930.
2. Dawson-Hughes B., Mithal A., Bonjour J.P., Boonen S., Burckhardt P., Fuleihan G.E., et al. IOF position statement: vitamin D recommendations for older adults. Osteoporos Int 2010, 21:1151-1154.
3. IOM Dietary reference ranges for calcium and vitamin D [access Feb13.2012]. http://www.iom.edu/Reports/2010/Dietary-Reference-Intakes-for-Calcium-and-Vitamin-D.aspx.
4. Bischoff-Ferrari H.A., Willett W.C., Wong J.B., Stuck A.E., Staehelin H.B., Orav E.J., et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 2009, 169:551-561.
5. Bischoff-Ferrari H.A., Orav E.J., Willett W.C., Meunier P., Lyons R.A., Lips P., et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med July 5th 2012.
6. van Schoor NM, Lips P. Worldwide vitamin D status. Best Pract Res Clin Endocrinol Metab Aug;25 2011, 4:671-680.
7. van der Wielen R.P., Lowik M.R., van den Berg H., de Groot L.C., Haller J., Moreiras O., et al. Serum vitamin D concentrations among elderly people in Europe. Lancet 1995, 346:207-210.
8. Bischoff-Ferrari H.A., Shao A., Dawson-Hughes B., Hathcock J., Giovannucci E., Willett W.C. Benefit-risk assessment of vitamin D supplementation. Osteoporos Int 2010, 21:1121-1132.
9. Gallagher J.C., Sai A., Templin T., Smith L. Dose response to vitamin D supplementation in postmenopausal women: a randomized trial. Ann Intern Med 2012, 156:425-437.
10. Lips P., Wiersinga A., van Ginkel F.C., Jongen M.J., Netelenbos J.C., Hackeng W.H., et al. The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. J Clin Endocrinol Metab 1988, 67:644-650.
11. Haddad J.G., Rojanasathit S. Acute administration of 25-hydroxycholecalciferol in man. J Clin Endocrinol Metab 1976, 42:284-290.
12. Hahn T.J., Halstead L.R., Teitelbaum S.L., Hahn B.H. Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration. J Clin Invest 1979, 64:655-665.
13. Stamp T.C., Haddad J.G., Twigg C.A. Comparison of oral 25-hydroxycholecalciferol, vitamin D, and ultraviolet light as determinants of circulating 25-hydroxyvitamin D. Lancet 1977, 1:1341-1343.
14. Colodro I.H., Brickman A.S., Coburn J.W., Osborn T.W., Norman A.W. Effect of 25-hydroxy-vitamin D3 on intestinal absorption of calcium in normal man and patients with renal failure. Metabolism 1978, 27:745-753.
15. Stamp T.C. Intestinal absorption of 25-hydroxycholecalciferol. Lancet 1974, 2:121-123.
16. Francis R.M., Peacock M., Storer J.H., Davies A.E., Brown W.B., Nordin B.E. Calcium malabsorption in the elderly: the effect of treatment with oral 25-hydroxyvitamin D3. Eur J Clin Invest 1983, 13:391-396.
17. 3 in raising wintertime serum 25-hydroxyvitamin D in older adults. Am J Clin Nutr 2012, 95:1350-1356.
18. Garcia-Delgado I., Prieto S., Gil-Fraguas L., Robles E., Rufilanchas J.J., Hawkins F. Calcitonin, etidronate, and calcidiol treatment in bone loss after cardiac transplantation. Calcif Tissue Int 1997, 60:155-159.
19. Sosa M., Lainez P., Arbelo A., Navarro M.C. The effect of 25-dihydroxyvitamin D on the bone mineral metabolism of elderly women with hip fracture. Rheumatology (Oxford) 2000, 39:1263-1268.
20. 3 and calcium in kidney transplant patients. Transplant Proc 1996, 28:3485-3487.
21. 3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J Clin Endocrinol Metab 2000, 85:3011-3019.
22. 3: effects on 25(OH)D levels, lower extremity function, blood pressure and markers of innate immunity. J Bone Miner Res Jan. 27 2012, 1:160-169.
23. 3. Clin Chem 2005, 51:1683-1690.
24. Saenger A.K., Laha T.J., Bremner D.E., Sadrzadeh S.M. Quantification of serum 25-hydroxyvitamin D(2) and D(3) using HPLC-tandem mass spectrometry and examination of reference intervals for diagnosis of vitamin D deficiency. Am J Clin Pathol 2006, 125:914-920.
25. NIST/NIH Vitamin D Metabolites Quality Assurance Program [access Aug 02, 2013]. http://www.nist.gov/mml/csd/vitdqap.cfm.
26. Barger-Lux M.J., Heaney R.P., Dowell S., Chen T.C., Holick M.F. Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int 1998, 8:222-230.